<DOC>
	<DOCNO>NCT02075294</DOCNO>
	<brief_summary>It estimate 350-400 million people chronic infection hepatitis B virus ( HBV ) world . In china , 93 million individual suffer chronic condition . Currently , seven medication approve treatment hepatitis B : two formulation interferon four nucleos ( ) ide analogue . The Chinese population one long average life span , size age population increase rapidly . As result , prevalence elderly patient HBV increase , potential development cirrhosis hepatocellular carcinoma patient real . Hence , treatment elderly patient HBV important issue . However , ADV ETV become first choice due side effect INF resistant LAM LdT . But treatment outcome ADV ETV elderly know yet . In study , evaluate compare efficacy tolerability ADV ETV young old patient HBV . The aims present study ( 1 ) ass benefit ADV ETV therapy elderly patient chronic hepatitis B , ( 2 ) determine difference emergence rate side effect .</brief_summary>
	<brief_title>Efficacy Safety Study Adefovir Entecavir Elderly With Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>1 . Age≥18 year 2 . HBsAg positive 6 month enrollment 3 . Serum HBVDNA ＞2×104IU/ml serum ALT ＞80U/L TBIL &lt; 34 umol/L chronic hepatitis B 4 . Serum ALT &lt; 80U/L , hepatic inflammation score ≥ G2 hepatic fibrosis stage ≥ S2 chronic hepatitis B 5 . Serum HBVDNA ＞40 IU/ml cirrhosis regardless ALT TBIL 1 . Coinfected HCV , HDV HIV , autoimmune liver disease combine 2. received antiviral therapy immunosuppressant drug 6 month prior enrollment 3 . Renal function : creatinine ＞1.5 ULN eGFR＜ 50ml/min/1.73m2 therapy 4 . Combined hepatocarcinoma therapy 5. suspend therapy voluntarily 6. use nephrotoxic drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Aged</keyword>
	<keyword>Hepatitis B , Chronic</keyword>
	<keyword>Antiviral Agents</keyword>
</DOC>